ASweetLife Team, Author at ASweetLife

Positive Results for Echo Therapeutics’ Transdermal Continuous Glucose Monitoring System

Echo Therapeutics announced positive results from its clinical trial of the Symphony tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system, in major general surgery and cardiothoracic surgery patients. This study is the second of two studies in critically ill patients. Data from this study demonstrate that Symphony successfully and continuously monitored glucose levels in the intensive care unit at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.

New Diabetes Venture: Eli Lilly and Boehringer Ingelheim to Develop and Market New Diabetes Drugs

Eli Lilly and Company and Boehringer Ingelheim announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development. Included are Boehringer Ingelheim's two oral diabetes agents—linagliptin and BI10773—as well as Lilly's two basal insulin analogues—LY2605541 and LY2963016—as well as the option to co-develop and co-commercialize Lilly's anti-TGF-beta monoclonal antibody.

Pumping Insulin, The Fifth Edition

We recently received a copy of Pumping Insulin, the 5th Edition, which provides up-to-date information on how to use an insulin pump to achieve the best blood glucose management. The book provides clear, logical steps on how to set up a pump test and adjust it. It demonstrates simple ways to find your total daily dose of insulin, basal rate and carb and correction factors for boluses, and how to use the bolus calculator to avoid stacking insulin and highs and lows.

NIH Awards Biodel Grant to Develop Ultra-Rapid-Acting Insulin for Use in Artificial Pancreas

The Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.

Jentadueto Approved in Europe for Treatment of Adults with Type 2 Diabetes

The European Commission has given Marketing Authorization to Jentadueto (linagliptin/metformin hydrochloride) tablets,Boehringer Ingelheim and Eli Lilly's medicine combining the DPP-4 inhibitor, linagliptin (the active ingredient in Tradjenta tablets, marketed under the trade name Trajenta in Europe) and metformin in a single tablet taken twice daily.

FDA Clears Roche’s Accu-Chek Combo System

Roche announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for the Accu-Chek Combo system for insulin pump therapy. The Accu-Chek Combo system seamlessly combines a blood glucose meter with an insulin pump, which are able to exchange data in both directions via Bluetooth wireless technology.

Low Carb Bagels

Recently, Mike posted a recipe for lox and cream cheese without the bagel, which triggered a number of bagel discussions. What is brunch, you asked us, without the bagel? No more complaining for those of you who want to keep eating bagels. Brunch need not be a choice between a hard boiled egg or a doughy ring of 60 grams of carb.